Your browser doesn't support javascript.
loading
Elevated cardiovascular risk and acute events in hospitalized colon cancer survivors: A decade-apart study of two nationwide cohorts.
Desai, Rupak; Mondal, Avilash; Patel, Vivek; Singh, Sandeep; Chauhan, Shaylika; Jain, Akhil.
Afiliação
  • Desai R; Independent Researcher, Atlanta, GA 30079, United States.
  • Mondal A; Department of Internal Medicine, Nazareth Hospital, Philadelphia, PA 19152, United States.
  • Patel V; Department of Internal Medicine, Nazareth Hospital, Philadelphia, PA 19152, United States.
  • Singh S; Department of Clinical Epidemiology, Biostatistics and Bio-informatics, Amsterdam UMC, Amsterdam 7057, Netherlands.
  • Chauhan S; Department of Internal Medicine, Geisinger Health System, Wikes-Barre, PA 18702, United States. drshaylikachauhan@gmail.com.
  • Jain A; Division of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77079, United States.
World J Clin Oncol ; 15(4): 548-553, 2024 Apr 24.
Article em En | MEDLINE | ID: mdl-38689632
ABSTRACT

BACKGROUND:

Over the years, strides in colon cancer detection and treatment have boosted survival rates; yet, post-colon cancer survival entails cardiovascular disease (CVD) risks. Research on CVD risks and acute cardiovascular events in colorectal cancer survivors has been limited.

AIM:

To compare the CVD risk and adverse cardiovascular outcomes in current colon cancer survivors compared to a decade ago.

METHODS:

We analyzed 2007 and 2017 hospitalization data from the National Inpatient Sample, studying two colon cancer survivor groups for CVD risk factors, mortality rates, and major adverse events like pulmonary embolism, arrhythmia, cardiac arrest, and stroke, adjusting for confounders via multivariable regression analysis.

RESULTS:

Of total colon cancer survivors hospitalized in 2007 (n = 177542) and 2017 (n = 178325), the 2017 cohort often consisted of younger (76 vs 77 years), male, African-American, and Hispanic patients admitted non-electively vs the 2007 cohort. Furthermore, the 2017 cohort had higher rates of smoking, alcohol abuse, drug abuse, coagulopathy, liver disease, weight loss, and renal failure. Patients in the 2017 cohort also had higher rates of cardiovascular comorbidities, including hypertension, hyperlipidemia, diabetes, obesity, peripheral vascular disease, congestive heart failure, and at least one traditional CVD (P < 0.001) vs the 2007 cohort. On adjusted multivariable analysis, the 2017 cohort had a significantly higher risk of pulmonary embolism (PE) (OR 1.47, 95%CI 1.37-1.48), arrhythmia (OR 1.41, 95%CI 1.38-1.43), atrial fibrillation/flutter (OR 1.61, 95%CI 1.58-1.64), cardiac arrest including ventricular tachyarrhythmia (OR 1.63, 95%CI 1.46-1.82), and stroke (OR 1.28, 95%CI 1.22-1.34) with comparable all-cause mortality and fewer routine discharges (48.4% vs 55.0%) (P < 0.001) vs the 2007 cohort.

CONCLUSION:

Colon cancer survivors hospitalized 10 years apart in the United States showed an increased CVD risk with an increased risk of acute cardiovascular events (stroke 28%, PE 47%, arrhythmia 41%, and cardiac arrest 63%). It is vital to regularly screen colon cancer survivors with concomitant CVD risk factors to curtail long-term cardiovascular complications.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article